Pretreatment SUVmax as a Marker for Progression-Free Survival in Stage I NSCLC Treated With SBRT
Pract Radiat Oncol
.
2013 Apr-Jun;3(2 Suppl 1):S3-4.
doi: 10.1016/j.prro.2013.01.014.
Epub 2013 Mar 25.
Authors
Z D Horne
1
,
D A Clump
1
,
S Shah
1
,
J A Vargo
1
,
S A Burton
1
,
N A Christie
1
,
M J Schuchert
1
,
R J Landreneau
1
,
J D Luketich
1
,
D E Heron
1
Affiliation
1
University of Pittsburgh Medical Center, Pittsburgh, PA.
PMID:
24674539
DOI:
10.1016/j.prro.2013.01.014
No abstract available